Original insights on thrombospondin-1-related antireceptor strategies in cancer.
about
Predictive model of thrombospondin-1 and vascular endothelial growth factor in breast tumor tissueIntrinsic dynamics study identifies two amino acids of TIMP-1 critical for its LRP-1-mediated endocytosis in neurons.Plasma degradome affected by variable storage of human blood.The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide.Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.The Roles of Matricellular Proteins in Oncogenic Virus-Induced Cancers and Their Potential Utilities as Therapeutic Targets.RNA-seq transcriptome analysis of formalin fixed, paraffin-embedded canine meningioma.Plasma-derived extracellular vesicle proteins as a source of biomarkers for lung adenocarcinoma.Thrombospondin-1 is a multifaceted player in tumor progression.Association of breast carcinoma growth with a non-canonical axis of IFNγ/IDO1/TSP1.How Signaling Molecules Regulate Tumor Microenvironment: Parallels to Wound Repair.A drug development perspective on targeting tumor-associated myeloid cells.Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions.Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.Thrombospondin-targeting TAX2 peptide impairs tumor growth in preclinical mouse models of childhood neuroblastoma.TIPE2 is negatively correlated with tissue factor and thrombospondin-1 expression in patients with bronchial asthma.
P2860
Q33897971-93D52237-F610-4561-BB05-AEBBF86D1571Q33905528-854B2EC6-7B1F-4694-B1CD-58C7AB7BE3B9Q37286747-DC3441F7-E960-47C5-8DF3-585BC8EF943FQ38930113-DC703081-B1C1-4179-9AE3-5A33F90D12B7Q41331553-039F616C-D4AB-419E-960D-5D3647001704Q42391294-D2C8E1EF-085D-4740-9325-4A338C898BCCQ45325755-12CC6B6E-A503-4594-8FBB-1C446C8B4D44Q46274097-D8F40D32-2B1C-472E-A5D3-BB0E4B25A23DQ47097156-B6E930E3-BE57-48CC-931E-EF89F04535DAQ47120215-3975AE5B-9C52-4CD9-9E93-B14904994CF1Q47127514-AE6BE784-45D2-433E-85C7-2E9B749178BBQ47601253-0BADFE36-0F66-4CC3-83D9-0C14184B2916Q48652546-3256D0F5-4008-4C48-98B7-854EF85918A1Q50019794-895553FC-A3B6-46C1-8FFA-7A4DEF11827AQ50791944-F8B2A2BB-1FB3-434D-84AC-BA66C8A36B06Q51328292-DA27AB75-DC8A-4BED-A15C-C5D01FBAA09AQ52653060-CD2EB42F-3B9E-4D7E-86E8-667885F0657B
P2860
Original insights on thrombospondin-1-related antireceptor strategies in cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Original insights on thrombospondin-1-related antireceptor strategies in cancer.
@ast
Original insights on thrombospondin-1-related antireceptor strategies in cancer.
@en
type
label
Original insights on thrombospondin-1-related antireceptor strategies in cancer.
@ast
Original insights on thrombospondin-1-related antireceptor strategies in cancer.
@en
prefLabel
Original insights on thrombospondin-1-related antireceptor strategies in cancer.
@ast
Original insights on thrombospondin-1-related antireceptor strategies in cancer.
@en
P2860
P356
P1476
Original insights on thrombospondin-1-related antireceptor strategies in cancer.
@en
P2093
Albin Jeanne
Laurent Martiny
P2860
P356
10.3389/FPHAR.2015.00252
P577
2015-10-29T00:00:00Z